Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation

Annals of Clinical Psychiatry

Volumn 24, Issue 3, 2012, Pages 204-214

  Weckmann, Michelle T ^a   Gingrich, Roger ^a   Mills, James A ^a   Hook, Larry ^a   Beglinger, Leigh J ^b  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cancer; Delirium; Hematopoietic stem cell transplantation; Risk factors

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DELIRIUM; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; INCIDENCE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYELOMA; NEUROPSYCHOLOGICAL TEST; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANEMIA; ANOXIA; BLOOD UREA NITROGEN; CREATININE; DEHYDRATION; DELIRIUM; ERYTHROCYTE INDICES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 84865218875     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fann JR. Neurological effects of psychopharmacological agents. Semin Clin Neuropsychiatry. 2002;7:196-205.
2. Gaudreau JD, Gagnon P, Harel F, et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol. 2005;23:6712-6718. (Pubitemid 46190266)
3. Morita T, Tei Y, Tsunoda J, et al. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage. 2001;22:997-1006. (Pubitemid 33152685)
4. Koster S, Hensens AG, Schuurmans MJ, et al. Consequences of delirium after cardiac operations. Ann Thorac Surg. 2012;93:705-711.
5. Wada T, Wada M, Wada M, et al. Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care. 2010;8:125-131.
6. Beglinger LJ, Duff K, Van Der Heiden S, et al. Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant. 2006;12:928-935.
7. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med. 2004;3:184-194. (Pubitemid 38771658)
8. Bruera E, Bush SH, Willey J, et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer. 2009;115:2004-2012.
9. Cobb J, Glantz MJ, Nicholas PK, et al. Delirium in patients with cancer at the end of life. Cancer Pract. 2000;8:172-177. (Pubitemid 30469675)
10. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350-364. (Pubitemid 43941802)
11. Fong TG, Jones RN, Shi P, et al. Delirium accelerates cognitive decline in Alzheimer disease. Neurology. 2009;72:1570-1575.
12. Fann JR, Alfano CM, Roth-Roemer S, et al. Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol. 2007;25:1223-1231. (Pubitemid 46640568)
13. Olofsson SM, Weitzner MA, Valentine AD, et al. A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer. 1996;4:351-357. (Pubitemid 126473708)
14. Ljubisavljevic V, Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry. 2003;25:345-352. (Pubitemid 37102942)
15. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160:786-794. (Pubitemid 30165239)
16. Gandreu J, Gagnon P, Harel F, et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol. 2005;23:6712-6718. (Pubitemid 46190266)
17. Fann JR, Roth-Roemer S, Burington BE, et al. Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer. 2002;95:1971-1981.
18. Fann JR, Hubbard RA, Alfano CM, et al. Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2011;29:895-901.
19. Beglinger LJ, Duff K, Van Der Heiden S, et al. Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study. J Int Neuropsychol Soc. 2007;13:172-177. (Pubitemid 46487388)
20. Beglinger LJ, Mills JA, Vik SM, et al. The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients. Arch Clin Neuropsychol. 2011;26:98-109.
21. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912-2919. (Pubitemid 41510773)
22. Sorror ML, Giralt S, Sandmaier BM, et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood. 2007;110:4606-4613. (Pubitemid 351377830)
23. de Borja MT, Chow E, Bovett G, et al. The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales. Support Cancer Ther. 2004;2:59-63.
24. Ma C, Bandukwala S, Burman D, et al. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer. 2010;46:3175-3183.
25. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988;23:89-97. (Pubitemid 18038426)
26. Trzepacz PT, Mittal D, Torres R, et al. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001;13:229-242. (Pubitemid 32499675)
27. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage. 1997;13:128-137. (Pubitemid 27172870)
28. Lawlor PG, Fainsinger RL, Bruera ED. Delirium at the end of life: critical issues in clinical practice and research. JAMA. 2000;284:2427-2429.
29. Cox DR. Regression tables and life tables. Journal of the Royal Statistical Society Series B. 1972;34:187-202.
30. Efron B. The efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association. 1977;72:557-565.
31. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological). 1995;57:289-300.
32. Fann JR. The epidemiology of delirium: a review of studies and methodological issues. Semin Clin Neuropsychiatry. 2000;5:64-74.
33. Prieto J, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907-1917. (Pubitemid 34273283)
34. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc. 2005;53:1658-1666. (Pubitemid 43109927)
35. Björkelund KB, Hommel A, Thorngren KG, et al. Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol Scand. 2010;54:678-688.
36. Inouye SK, Zhang Y, Jones RN, et al. Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med. 2007;167:1406-1413. (Pubitemid 47052440)
37. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics. 2002;43:183-194. (Pubitemid 34522528)
38. Sagawa R, Akechi T, Okuyama T, et al. Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients. Jpn J Clin Oncol. 2009;39:175-182.
39. Shiiba M, Takei M, Nakatsuru M, et al. Clinical observations of postoperative delirium after surgery for oral carcinoma. Int J Oral Maxillofac Surg. 2009;38:661-665.
40. Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 1994;271:134-139. (Pubitemid 24020590)
41. Fann JR, Alfano CM, Burington BE, et al. Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer. 2005;103:810-820. (Pubitemid 40216411)
42. Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci. 2003;58:76-81. (Pubitemid 36110059)
43. Robinson S, Vollmer C. Undermedication for pain and precipitation of delirium. Medsurg Nurs. 2010;19:79-83.
44. Larsen KA, Kelly SE, Stern TA, et al. Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics. 2010;51:409-418.